Substituted carboxamides as inhibitors of WDR5 protein-protein binding
Rima Al-Awar, Toronto (CA); Carlos Armando Zepeda-Velazquez, Mississauga (CA); Gennady Poda, Toronto (CA); Methvin Isaac, Brampton (CA); David Uehling, Toronto (CA); Brian Wilson, Mississauga (CA); Babu Joseph, Oakville (CA); Yong Liu, Oakville (CA); Pandiaraju Subramanian, Oakville (CA); Ahmed Mamai, Mississauga (CA); Michael Prakesch, Toronto (CA); and Julia Katheleen Stille, Ottawa (CA)
Assigned to Propellon Therapeutics Inc., Toronto (CA)
Filed by Propellon Therapeutics Inc., Toronto (CA)
Filed on May 6, 2022, as Appl. No. 17/738,707.
Application 17/738,707 is a continuation of application No. 17/484,534, filed on Sep. 24, 2021, abandoned.
Application 17/484,534 is a continuation of application No. 16/080,866, granted, now 11,319,299, issued on May 3, 2022, previously published as PCT/CA2017/050269, filed on Mar. 1, 2017.
Claims priority of provisional application 62/301,673, filed on Mar. 1, 2016.
Prior Publication US 2023/0219926 A1, Jul. 13, 2023